Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Finished Goods (2023 - 2025)

SRx Health Solutions (SRXH) has disclosed Finished Goods for 3 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Finished Goods fell 54.41% year-over-year to $1.5 million, compared with a TTM value of $1.5 million through Sep 2025, down 54.41%, and an annual FY2025 reading of $1.5 million, changed N/A over the prior year.
  • Finished Goods was $1.5 million for Q3 2025 at SRx Health Solutions, down from $4.6 million in the prior quarter.
  • Across five years, Finished Goods topped out at $5.5 million in Q4 2023 and bottomed at $1.5 million in Q3 2025.
  • Average Finished Goods over 3 years is $3.6 million, with a median of $3.6 million recorded in 2024.
  • The sharpest move saw Finished Goods tumbled 43.54% in 2024, then tumbled 54.41% in 2025.
  • Year by year, Finished Goods stood at $5.5 million in 2023, then crashed by 43.54% to $3.1 million in 2024, then tumbled by 50.52% to $1.5 million in 2025.
  • Business Quant data shows Finished Goods for SRXH at $1.5 million in Q3 2025, $4.6 million in Q2 2025, and $3.8 million in Q1 2025.